Corient Capital Partners’s Synopsys SNPS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$1.36M Buy
4,466
+433
+11% +$147K 0.1% 168
2022
Q2
$1.22M Buy
4,033
+689
+21% +$208K 0.09% 190
2022
Q1
$1.11M Buy
3,344
+742
+29% +$232K 0.07% 229
2021
Q4
$959K Buy
2,602
+79
+3% +$26.6K 0.06% 232
2021
Q3
$755K Sell
2,523
-297
-11% -$90.2K 0.06% 269
2021
Q2
$778K Buy
2,820
+213
+8% +$54.1K 0.06% 262
2021
Q1
$646K Buy
2,607
+267
+11% +$67.8K 0.06% 270
2020
Q4
$607K Buy
2,340
+159
+7% +$36.7K 0.06% 245
2020
Q3
$467K Sell
2,181
-56
-3% -$11.4K 0.05% 263
2020
Q2
$437K Buy
2,237
+270
+14% +$44.6K 0.05% 270
2020
Q1
$253K Buy
1,967
+58
+3% +$8.25K 0.04% 326
2019
Q4
$265K Buy
1,909
+159
+9% +$21.8K 0.03% 385
2019
Q3
$241K Buy
1,750
+100
+6% +$13.5K 0.03% 378
2019
Q2
$212K Buy
+1,650
New +$198K 0.03% 363

Other funds holding SNPS

Corient Capital Partners's SNPS Position: Q3 2022 in Review

Corient Capital Partners increased its Synopsys (SNPS) stake by 11% in Q3 2022, buying an estimated $147K and bringing the position to 4,466 shares worth $1.36M. The position accounts for 0.1% of the portfolio, ranked #168.

Corient Capital Partners first reported a position in SNPS in Q2 2019 and has held it in 14 quarters since. 878 funds tracked by Wall St. Rank hold SNPS as of Q3 2022.

  • Corient Capital Partners held 4,466 shares of Synopsys worth $1.36M as of Q3 2022.
  • Corient Capital Partners bought 433 Synopsys shares in Q3 2022, an estimated $147K.
  • Synopsys made up 0.1% of Corient Capital Partners's portfolio in Q3 2022, its #168 holding.
  • Corient Capital Partners first reported a position in Synopsys in Q2 2019 and has held it in 14 quarters since.
  • 878 funds tracked by Wall St. Rank held Synopsys as of Q3 2022.

Based on Corient Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.